Hsbc Holdings PLC Vertex Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 855,016 shares of VRTX stock, worth $386 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
855,016
Previous 904,742 5.5%
Holding current value
$386 Million
Previous $424 Million 6.23%
% of portfolio
0.24%
Previous 0.27%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $22.9 Million - $25.2 Million
-49,726 Reduced 5.5%
855,016 $398 Million
Q2 2024

Aug 12, 2024
BUY
$392.81 - $485.53 $38.8 Million - $48 Million
98,800 Added 12.26%
904,742 $424 Million
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $78 Million - $85.3 Million
191,273 Added 31.12%
805,942 $337 Million
Q4 2023

Feb 12, 2024
BUY
$343.0 - $410.68 $18.5 Million - $22.1 Million
53,862 Added 9.6%
614,669 $250 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $41.1 Million - $44 Million
-121,386 Reduced 17.79%
560,807 $195 Million
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $37.4 Million - $41.8 Million
118,878 Added 21.1%
682,193 $240 Million
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $21.2 Million - $24.1 Million
74,725 Added 15.29%
563,315 $177 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $50.5 Million - $56.8 Million
176,722 Added 56.67%
488,590 $141 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $5.17 Million - $5.77 Million
-18,892 Reduced 5.71%
311,868 $90.9 Million
Q2 2022

Aug 11, 2022
SELL
$234.96 - $292.55 $4.1 Million - $5.11 Million
-17,468 Reduced 5.02%
330,760 $93.2 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $6.86 Million - $8.09 Million
-30,985 Reduced 8.17%
348,228 $90.5 Million
Q4 2021

Feb 11, 2022
SELL
$177.01 - $223.45 $3.87 Million - $4.88 Million
-21,846 Reduced 5.45%
379,213 $83.3 Million
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $7.78 Million - $8.71 Million
42,914 Added 11.98%
401,059 $72.9 Million
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $10.6 Million - $12.5 Million
56,678 Added 18.8%
358,145 $72.2 Million
Q1 2021

May 14, 2021
SELL
$207.02 - $241.31 $12.1 Million - $14.1 Million
-58,268 Reduced 16.2%
301,467 $64.8 Million
Q4 2020

Feb 25, 2021
SELL
$207.01 - $276.09 $6.19 Million - $8.26 Million
-29,900 Reduced 7.67%
359,735 $85 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $18.8 Million - $25.1 Million
90,971 Added 30.46%
389,635 $92.1 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $19.1 Million - $22.6 Million
74,598 Added 33.29%
298,664 $81.3 Million
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $672,606 - $882,371
-2,983 Reduced 1.31%
224,066 $65 Million
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $3.34 Million - $4.14 Million
16,710 Added 7.94%
227,049 $53.5 Million
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $10.7 Million - $14.3 Million
-64,040 Reduced 23.34%
210,339 $47 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $3.76 Million - $4.23 Million
22,616 Added 8.98%
274,379 $46.5 Million
Q2 2019

Aug 13, 2019
BUY
$164.61 - $190.37 $15.4 Million - $17.9 Million
93,849 Added 59.43%
251,763 $46.2 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $2.12 Million - $2.52 Million
12,924 Added 8.91%
157,914 $29 Million
Q4 2018

Feb 13, 2019
SELL
$151.91 - $192.21 $10.2 Million - $12.9 Million
-66,863 Reduced 31.56%
144,990 $23.8 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $2.98 Million - $3.43 Million
17,772 Added 9.16%
211,853 $40.8 Million
Q2 2018

Aug 10, 2018
SELL
$145.72 - $169.96 $12.7 Million - $14.8 Million
-86,920 Reduced 30.93%
194,081 $33 Million
Q1 2018

May 11, 2018
BUY
$151.6 - $177.13 $4.4 Million - $5.15 Million
29,050 Added 11.53%
281,001 $45.8 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $8.44 Million - $9.56 Million
-61,476 Reduced 19.61%
251,951 $37.8 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $8.54 Million - $9.36 Million
57,668 Added 22.55%
313,427 $47.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
255,759
255,759 $33 Million

Others Institutions Holding VRTX

# of Institutions
1,721
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email